Radioimmunodetection < Radioimmunotherapy < Radioisotope Dilution Technique

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 227.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000360 (2013)		Enhanced tumor retention of a radiohalogen label for site-specific modification of antibodies.
000A45 (2013)		Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma.
000C22 (2012)		Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
000C28 (2012)		¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
000C29 (2012)		Clinical trial of the intratumoral administration of labeled DC combined with systemic chemotherapy for esophageal cancer.
000D79 (2012)		Effect of small-molecule-binding affinity on tumor uptake in vivo: a systematic study using a pretargeted bispecific antibody.
000E51 (2012)		Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC).
000F62 (2012)		Feasibility of bremsstrahlung dosimetry for direct dose estimation in patients undergoing treatment with 90Y-ibritumomab tiuxetan.
000F70 (2012)		In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy.
001015 (2012)		Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging.
001210 (2011)		Patient-specific dosimetry in radionuclide therapy.
001222 (2011)		Auger electron radioimmunotherapeutic agent specific for the CD123+/CD131- phenotype of the leukemia stem cell population.
001555 (2011)		Biodistribution and dosimetry of In-111/Y-90-HuCC49ΔCh2 (IDEC-159) in patients with metastatic colorectal adenocarcinoma.
001573 (2011)		Engineering an antibody with picomolar affinity to DOTA chelates of multiple radionuclides for pretargeted radioimmunotherapy and imaging.
001624 (2011)		Adjuvant radioimmunotherapy improves survival of rats after resection of colorectal liver metastases.
001698 (2010)		90Y Bremsstrahlung imaging for absorbed-dose assessment in high-dose radioimmunotherapy.
001727 (2010)		Current concepts and future directions in radioimmunotherapy.
001850 (2010)		Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.
001891 (2010)		Antitumor effects and normal-tissue toxicity of 111In-nuclear localization sequence-trastuzumab in athymic mice bearing HER-positive human breast cancer xenografts.
001B03 (2010)		High-dose radioimmunotherapy combined with extracorporeal depletion in a syngeneic rat tumor model: evaluation of toxicity, therapeutic effect, and tumor model.
001B04 (2010)		Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Radioimmunotherapy" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Radioimmunotherapy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Radioimmunotherapy
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024